Sooma

Sooma Medical Ltd is developing, manufacturing and marketing a non-invasive therapy device for neurological and psychiatric disorders (depression and chronic pain). Sooma uses transcranial direct current stimulation (tDCS) technology. Sooma technology is trusted by over 100 clinics worldwide. Their first product is the first portable device approved for the treatment of major depressive disorder (MDD). The device is CE-approved and currently marketed in the EU and other selected markets. Their quality management system has been awarded with ISO 13485:2016 and MDSAP certificates. In the U.S. the FDA limits the use of the tDCS for investigational use only. Sooma products are distributed in over 30 countries.